SLC35B4
Nucleotide sugar transporter SLC35B4
Also known as: FLJ14697, S35B4_HUMAN, YEA4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969S0
- Gene
- SLC35B4
- Ensembl
- ENSG00000205060
- Chromosome
- 7
- Canonical length
- 331 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Glycosyltransferases, such as SLC35B4, transport nucleotide sugars from the cytoplasm where they are synthesized, to the Golgi apparatus where they are utilized in the synthesis of glycoproteins, glycolipids, and proteoglycans (Ashikov et al., 2005 [PubMed 15911612]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
331 residues, UniProt reviewed canonical sequence.
>Q969S0|SLC35B4
1 MRPALAVGLV FAGCCSNVIF LELLARKHPG CGNIVTFAQF LFIAVEGFLF EADLGRKPPA
61 IPIRYYAIMV TMFFTVSVVN NYALNLNIAM PLHMIFRSGS LIANMILGII ILKKRYSIFK
121 YTSIALVSVG IFICTFMSAK QVTSQSSLSE NDGFQAFVWW LLGIGALTFA LLMSARMGIF
181 QETLYKRFGK HSKEALFYNH ALPLPGFVFL ASDIYDHAVL FNKSELYEIP VIGVTLPIMW
241 FYLLMNIITQ YVCIRGVFIL TTECASLTVT LVVTLRKFVS LIFSILYFQN PFTLWHWLGT
301 LFVFIGTLMY TEVWNNLGTT KSEPQKDSKK NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC35B4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 13 nTPM
- retina: 11 nTPM
- placenta: 11 nTPM
- cerebral cortex: 10 nTPM
- kidney: 9.8 nTPM
- liver: 8 nTPM
Single-cell type
- distal convoluted tubule cells: 150 nCPM
- cytotrophoblasts: 140 nCPM
- syncytiotrophoblasts: 122 nCPM
- migrating cytotrophoblasts: 93 nCPM
- renal connecting tubule cells: 93 nCPM
- megakaryocytes: 56 nCPM
Immune cell
- myeloid DC: 3.1 nTPM
- MAIT T-cell: 2.5 nTPM
- naive CD8 T-cell: 2.2 nTPM
- intermediate monocyte: 2.1 nTPM
- memory CD8 T-cell: 2.1 nTPM
- plasmacytoid DC: 2.1 nTPM
Brain region
- hypothalamus: 27 nTPM
- cerebellum: 26 nTPM
- midbrain: 24 nTPM
- basal ganglia: 24 nTPM
- thalamus: 24 nTPM
- medulla oblongata: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.2
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- regulation of gluconeogenesis
- UDP-N-acetylglucosamine transmembrane transport
- UDP-xylose transmembrane transport
Molecular functions
- UDP-N-acetylglucosamine transmembrane transporter activity
- UDP-xylose transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC35B4 as an antibody target. Whether an autoantibody or antibody against SLC35B4 could matter depends on whether native SLC35B4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC35B4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC35B4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...